Diligence memo · auto-generated · as of July 2, 2026
Quibble Genomics Institute
Quibble Genomics Institute looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Quibble Genomics Institute operates in Other Health Care, based in THOUSAND OAKS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Quibble Genomics Institute has raised $26M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $26M on —.
Valuation (modeled)modeled
Provath models Quibble Genomics Institute at approximately $93M (range $62M–$114M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.30× the median modeled value of Series B Other Health Care companies (458 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
Comparablesmixed
Capital scale ranks ahead of 87% of Other Health Care peers (5377 compared).
Modeled value ranks above 78% of those peers.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.